Purple Cell

Archives: Resources

PPD Inc | Article
New Growth and Decline in Asia Clinical Trials
  • PDF (151.51 KB)

Clinical trial demands are high for the growing expertise in Asian countries.

Read More
PPD Inc | Article
The Dynamic Evolution of Multi-sponsor REMS
  • PDF (766.06 KB)

A brief background of REMS programs; dramatic shifts in the types of REMS approved; challenges associated with multi-sponsor REMS; and how to ensure that your company and products are prepared.

Read More
PPD Inc | Article
Adapting to Adaptive Drug Development
  • PDF (603.16 KB)

Jürgen Hummel, PPD’s associate statistical science director, was featured in the June issue of PharmaVOICE.

Read More
PPD Inc | Article
Innovation Tied to Globalization & Collaboration
  • PDF (234.90 KB)

The article discusses the increasing frequency and value of strategic partnerships in driving research advancements.

Read More
PPD Inc | Article
Better Development of Biosimilars

In the May/June 2013 issue of Drug Discovery & Development, PPD experts discuss how Bayesian modeling can leverage data to aid development of biosimilars.

PPD Inc | Article
Biosimilars Update Contract Pharma

PPD’s Dirk Reitsma VP and therapeutic head for oncology, was a featured subject matter expert in the April issue of Contract Pharma.

PPD Inc | Report
French Sunshine Act – French Transparency Report
  • PDF (79.92 KB)

Review PPD’s 1 October 2013 French Sunshine Act document.

Read More
PPD Inc | Legal Documents
French Sunshine Act – Description of terms
  • XLSX (12.87 KB)

Review the French Sunshine Act description of terms document.

Read More
PPD Inc | Case Study
Force Degradation of an Oligonucleotide
  • PDF (69.21 KB)

A case study about Force Degradation of an Oligonucleotide

Read More